Loading clinical trials...

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study | Clinical Trials | Clareo Health

RECRUITING

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

NCT00616317•University of California, Davis

View on ClinicalTrials.gov

Summary

The purpose of this study is to gather information about causes and treatment of Antiphospholipid Syndrome.

Eligibility

Age

0 - 18 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•18 years of age or younger at the onset of disease
•Presence of Vascular Thrombosis
•UC Davis patient
•Presence of at least one Laboratory criteria including: Anticardiolipin antibody, Anti-B glycoprotein-I antibody or Lupus anticoagulant in plasma

Exclusion Criteria

•Infants born to mothers with APS
•Infants with congenital thrombophilia

Locations (1)

UC Davis Medical Center

Sacramento, California, United States

Key Dates

Start Date

September 1, 2006

Primary Completion Date

January 1, 2040

Completion Date

January 1, 2040

Last Updated

December 5, 2025

Enrollment

ESTIMATED participants

Conditions

Antiphospholipid Syndrome

Contacts

Lavjay Butani

CONTACT

(916) 734-8118

Rheumatology Patient Registry and Biorepository

NCT04402086

Rheumatic DiseasesAdult Onset Still Disease+18 more

View study

RECRUITINGPHASE1/PHASE2

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

NCT06828042

Systemic Lupus ErthematosusSystemic Sclerosis (SSc)+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 5, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study

Inclusion Criteria

Exclusion Criteria

Rheumatology Patient Registry and Biorepository

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE